Introduction 36
Flavobacterium psychrophilum, a Gram-negative, filamentous, psychrotrophic bacterium, 37 is the aetiological agent of rainbow trout fry syndrome (RTFS) and bacterial coldwater Bacterial isolates and growth conditions 80 A total of 140 F. psychrophilum isolates, previously described by Ngo et al. (2017) for 81 genetic and serological diversity, were examined in this study. This collection comprised The 125 isolates from 27 sites within the UK in this study had been isolated 99 between 2005 and 2015 with the majority (110 strains, 88%) being retrieved between 100 2011 and 2013. Among these isolates, 51 genotypes and 7 plasmid profiles were detected (Ngo et al. 2017) (Table 1) . However, within this set of 125 isolates, there were five (CLSI 2006) . Therefore, the F. psychrophilum type strain NCIMB 1947 T was also 144 included in every test run to monitor the performance of the method. The antimicrobial susceptibility patterns of 133 F. psychrophilum isolates used in this 148 study were analysed by application of protocol and species-specific epidemiological cut-149 off values (COWT). These values allow isolates to be categorised as fully susceptible 150 (wild type, WT) or manifesting reduced susceptibility (non-wild type, NWT). In this 151 work, COWT values were calculated for both the MIC and disc diffusion data by the 152 normalised resistance interpretation (NRI) method (Kronvall 2003; 2010 presented in Table 5 . The distribution of disc diffusion zones of the isolates for six 196 antimicrobials is presented in Figure 1 and the zone data-based COWT values of 197 antimicrobial agents are shown in Table 6 . MIC data for OTC showed a clear bimodal distribution ( Table 3 ). The modal group with 201 lower MICs was assumed to represent the WT group. NRI analysis calculated the 202 standard deviation of the log2 normalised WT distribution as 0.68 and a COWT value of 203 ≤0.25 mg L -1 (Table 5 ). Applying this cut-off, fifty-six (42%) of the 133 isolates analysed 204 were categorised as WT.
205
The disc diffusion zone sizes for OTC30 showed considerable diversity at the high 206 zone end ( Figure 1A ). However, NRI analysis of these data identified a high zone modal 207 group with a standard deviation of 7.44 mm. If this modal group was assumed to represent zones obtained from WT isolates, a provisional COWT value of ≥51 mm could 209 be calculated (Table 6 ). Applying this cut-off, sixty-five (49%) of the 133 isolates 210 analysed were categorised as WT.
211
The categorisation of isolates resulting from applying the cut-off of ≤0.25 mg L -1 to 212 the MIC data agreed with the categorisation resulting from applying the disc zone cut-off 213 of ≥51 mm to the zone data for 93% of the 133 isolates studied (Figure 2A ). (Table 3) . On this basis, neither of these data sets was considered suitable for NRI 219 analysis.
220
As in MIC data set for AMP there was a clear separation of the low MIC and high 221 MIC modal groups, this data set was considered suitable for estimating COWT by visual 222 examination. The estimated value generated by this subjective method was ≤0.125 mg L -1 223 for AMP. A scatterplot of the paired MIC data for these two beta-lactam agents ( Figure   224 3A) suggested a high correlation between them and also demonstrated that AMOX might 225 have the same distribution as AMP.
226
The disc diffusion zone sizes for AMOX10 were also bimodal ( Figure 1B ). NRI 227 analysis of these data calculated a standard deviation of the normalised WT distribution 228 of 5.2 mm and a COWT value of ≥56 mm (Table 6) MIC data for FFN showed a clear unimodal distribution (Table 3 ). This modal group was 234 assumed to represent the WT isolates. NRI analysis calculated a standard deviation of the 235 log2 normalised WT distribution of 0.68 and a COWT value of ≤2 mg L -1 (Table 5 ).
236
The disc diffusion zone sizes for FFN30 were also unimodal ( Figure 1C ). NRI 237 analysis of these data calculated a standard deviation of the normalised WT distribution 238 of 5.6 mm and a COWT value of ≥45 mm (Table 6 ).
239
Applying the cut-off of ≤2 mg L -1 to the MIC data and the disc zone cut-off of ≥41 240 mm to the zone data categorised 100% of the 133 isolates studied as WT ( Figure 2C ).
242

Oxolinic acid, Flumequine and Enrofloxacin 243
The MIC values of OXO, FLUQ and ENRO were bimodally distributed (Table 3) . NRI 244 analysis calculated the standard deviation of the log2 normalised WT distribution as 0.67, 245 0.57 and 0.74 for OXO, FLUQ and ENRO respectively. The MIC COWT values 246 calculated from these data were ≤0.25 mg L -1 for OXO, ≤0.125 mg L -1 for FLUQ and 247 ≤0.032 mg L -1 for ENRO (Table 5 ). When these COWT values were applied, 21 (16%), 20 248 (15%) and 20 (15%) of the 133 isolates were categorised as WT with respect to OXO, 249 FLUQ and ENRO respectively. The disc diffusion zone sizes for OXO2 were bimodal ( Figure 1D ). NRI analysis of 256 these data calculated a standard deviation of the normalised WT distribution of 8.5 mm.
257
This high standard deviation is probably a result of the fact that high zone modal group 258 was diverse and composed of only a few observations. This suggests that the disc COWT 259 value calculated by NRI analysis of ≥30 mm (Table 6 ) should only be treated as a 260 provisional value. Applying the cut-off of ≤0.25 mg L -1 to the MIC data for OXO and the 261 disc zone cut-off of ≥30 mm to the zone data resulted in 99% agreement in the 262 categorisation of the 133 isolates studied ( Figure 2D ).
263
The disc diffusion zone sizes for FLUQ were not determined and those for ENRO 264 did not show any visually obvious high zone modal group and were not subject to NRI 265 analysis ( Figure 1E ). The distributions of the MIC values for these two potentiated sulfonamide agents were 275 diverse but appeared to be unimodal (Table 3) . NRI analysis generated provisional COWT 276 values for PRI and SXT of ≤320 mg L -1 and ≤160 mg L -1 , respectively. However, the 277 standard deviations calculated for the normalized distribution of these putative WT 278 observations, 1.39 log2 mg L -1 and 1.67 log2 mg L -1 for PRI and SXT respectively, were 279 higher than those recorded for all other agents in this work (Table 5 ). Therefore, the 280 validity of these COWT values was questionable.
281
The disc diffusion zone sizes for SXT did not show any visually obvious high zone 282 modal group and were not subject to NRI analysis ( Figure 1F ). (Table 5 ) was 0.72 log2 mg L -1 . This suggests that the MIC data sets obtained in this work 295 for these agents were of an acceptable level of precision and were of sufficient quality 296 that they could be used to calculate COWT values.
297
The standard deviations calculated for potentiated sulphonamide MIC data, 1.39 298 log2 mg L -1 and 1.61 log2 mg L -1 for PRI and SXT respectively in this work, were, 299 however, considerably larger and were taken to indicate significant imprecision. Smith et 300 al. (2016) and Van Vliet et al. (2017) , who used the same testing protocol as was used in 301 this work also reported very low precision in the MIC data they obtained for these agents 302 (mean 1.43 log2 mg L -1 ). Due to their low precision, it was considered that valid COWT 303 could not be established for PRI and SXT data obtained in this work. data. The values of these categorical agreements were 100% for FFN, 99% for OXO and 334 93% for OTC. This high level of categorical agreement raise the possibility that, although 335 the disc diffusion protocol used in this work generated data of low precision, the provisional COWT calculated from them may have some value in detecting isolates of 337 reduced susceptibility.
338
It should, however be noted that Smith & Kronvall (2015) demonstrated that 339 reduced temperatures and prolonged incubation time increased not only the level of intra-340 laboratory variation but also the level of inter-laboratory variation in the data generated.
341
High inter-laboratory variation of the data will have the consequence that although any 342 provisional disc COWT calculated in one laboratory may have some value in interpreting 343 zone data produced in that laboratory, it may be misleading if applied to zone data 344 obtained in another laboratory. In other words, the COWT values for MIC data calculated 345 in this work are probably laboratory-independent and of general or 'universal' 346 applicability. However, it is probably safer to treat the COWT values for inhibition zone 347 data generated in this work as only of local applicability. As a consequence, each 348 laboratory using this protocol to perform disc diffusion assays would have to generate 349 their own COWT values. The disc diffusion test protocol used in this work has not been 350 accepted as a standard by CLSI. It is possible that further optimisation such as using a 351 higher incubation temperature (18 o C) may lead to a protocol with increased precision. 
363
It should, however, be noted that in this work, no isolates were recorded as manifesting 364 an MIC of 0.25 mg L -1 for OTC (Table 3) 
397
These anecdotal reports of comparative treatment efficacies reflect closely the 398 frequencies with which isolates of reduced susceptibility were detected in this work. This 399 in turn suggests that routine susceptibility testing, associated with appropriate 400 interpretation of these data obtained, would be cost-effective and an essential element in 401 the prudent use of antibiotics in aquaculture. -Jeffreys & Taylor (2015) reported that within the UK most batches of 403 rainbow trout were treated with FFN at least once during every production cycle. Thus, 404 given the relatively high frequency of NWT phenotypes detected with respect to the 405 alternative agents available (OXO, OTC and AMOX), it would appear that, as it currently 406 operates, the UK rainbow trout industry is critically dependent on the continued clinical 407 efficacy of FFN. Some concern must be expressed about the long-term sustainability of 408 an industry that would be affected by the emergence of strains of F. psychrophilum that 409 were clinically resistant to this agent.
Verner
410
As FFN is the agent of choice to treat F. psychrophilum infection in many countries, 411 it is reasonable to postulate that this critical dependence of the continued clinical efficacy 412 of FFN is not unique to the UK but is wide-spread in the global trout farming industry.
413
The global situation with respect to FFN susceptibility of F. psychrophilum can be 414 assessed from a number of studies that have been published. Studies that have employed 415 standard MIC testing protocols and that generated data of adequate precision have been 
